Abstract: Anti-PVRIG and anti-TIGIT antibodies are provided.

Abstract: Devices, systems, and methods corresponding to addressing misalignment in display systems are provided. A method includes using a first microelectromechanical system (MEMS) mirror, directing a first signal from a first light source to an alignment tracking waveguide. The method further includes receiving by a first photosensor a first portion of the first signal via the alignment tracking waveguide and determining a first alignment indicator associated with the first portion of the first signal. The method further includes using a second MEMS mirror, directing a second signal from a second light source to the alignment tracking waveguide. The method further includes receiving by a second photosensor a second portion of the second signal via the alignment tracking waveguide and determining a second alignment indicator associated with the second portion of the second signal.

Abstract: Devices, systems, and methods corresponding to addressing misalignment in display systems are provided. A method includes using a first microelectromechanical system (MEMS) mirror, directing a first signal from a first light source to an alignment tracking waveguide. The method further includes receiving by a first photosensor a first portion of the first signal via the alignment tracking waveguide and determining a first alignment indicator associated with the first portion of the first signal. The method further includes using a second MEMS mirror, directing a second signal from a second light source to the alignment tracking waveguide. The method further includes receiving by a second photosensor a second portion of the second signal via the alignment tracking waveguide and determining a second alignment indicator associated with the second portion of the second signal.

Abstract: A connector is provided for connecting an auxiliary device to a fluid circulating system. The connector comprises a body with inlet and outlet ports for connection to the fluid circulating system, and an auxiliary port for connection to the auxiliary device. The auxiliary port diverts fluid from the inlet to the auxiliary device and returns fluid to the outlet port. A collar surrounds the auxiliary port, secured by two spring clips. When the spring clips are both locked, movement between the connector and auxiliary device is prevented. When the first clip is released and the second clip is locked, rotation between the connector and the auxiliary device about the central axis and a predetermined amount of movement along the axis is permitted. The connector can be fitted in a variety of orientations relative to the auxiliary device and angular adjustment is possible while the two remain connected and sealed.

Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.

Abstract: A seal assembly includes a semi-tubular sealing element defining a longitudinal axis, and a retainer configured to retain the sealing element. The sealing element has a longitudinal center portion and first and second longitudinal side portions, an array of resilient arcuate fingers extending from the first longitudinal side portion and curving partially around the longitudinal axis, and a depressor portion extending from the second longitudinal side portion and having a free edge diametrically opposed to the center portion. The retainer defines a channel with an entrance opening, the channel being configured to receive the sealing element in a position in which the depressor portion extends outside of the entrance opening in position to bear a load, the channel being defined by a pair of opposed side walls configured to resiliently capture the sealing element.

Abstract: A seal assembly is configured to be installed in a sealing element retainer that includes a channel defined by a bottom wall and a pair of parallel longitudinal side walls. The seal assembly includes a sealing element having an elongate, arcuate spring portion defining a longitudinal axis, and a planar base portion, integral with the arcuate spring portion, that underlies the arcuate spring portion along the longitudinal axis and that is dimensioned to fit in the channel. A retention element is configured for engagement with the base portion of the sealing element to retain the sealing element in the channel.

Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.

Abstract: Pedestrian call systems with bidirectional communication between pedestrian call stations and traffic controllers are arranged so as to detect system errors. Communications can be provided over power conductors, and systems can be configured and monitored using a web browser. In one example, traffic systems are provided with Ethernet interfaces that can be used for bidirectional communication over power lines.

Abstract: Pedestrian call systems with bidirectional communication between pedestrian call stations and traffic controllers are arranged so as to detect system errors. Communications can be provided over power conductors, and systems can be configured and monitored using a web browser. In one example, traffic systems are provided with Ethernet interfaces that can be used for bidirectional communication over power lines.

Abstract: A seal assembly includes a semi-tubular sealing element defining a longitudinal axis, and a retainer configured to retain the sealing element. The sealing element has a longitudinal center portion and first and second longitudinal side portions, an array of resilient arcuate fingers extending from the first longitudinal side portion and curving partially around the longitudinal axis, and a depressor portion extending from the second longitudinal side portion and having a free edge diametrically opposed to the center portion. The retainer defines a channel with an entrance opening, the channel being configured to receive the sealing element in a position in which the depressor portion extends outside of the entrance opening in position to bear a load, the channel being defined by a pair of opposed side walls configured to resiliently capture the sealing element.

Abstract: Compositions comprising cyclic amino acids or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier. Said compositions are for use in the treatment of pain. Pain includes both acute and chronic forms of pain. The preferred cyclic amino acid is 1-aminocyclobutane-1-carboxylic acid (ACBC).

Abstract: A connector is provided for connecting an auxiliary device, such as a filter, to a fluid circulating system, such as a central heating system. The connector comprises a body with inlet and outlet ports, suitable for connection to the fluid circulating system, and an auxiliary port suitable for connection to the auxiliary device. The auxiliary port has a central axis and diverts fluid from the inlet to the auxiliary device and returns fluid therefrom to the outlet port. A collar surrounds the auxiliary port. First and second releasable locking means secure the collar to the auxiliary device. The locking means are arranged such that when both are locked relative movement between the connector and the auxiliary device is prevented. However, when the first locking means is released and the second locking means is locked, relative rotation between the connector and the auxiliary device about the central axis is permitted, and a predetermined amount of relative movement along the axis is also permitted.

Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.

Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.

Abstract: Pedestrian call systems with bidirectional communication between pedestrian call stations and traffic controllers are arranged so as to detect system errors. Communications can be provided over power conductors, and systems can be configured and monitored using a web browser. In one example, traffic systems are provided with Ethernet interfaces that can be used for bidirectional communication over power lines.

Abstract: Compositions comprising cyclic amino acids or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier. Said composition are for use in the treatment of pain. Pain includes both acute and chronic forms of pain. The preferred cyclic amino acid is 1-aminocyclobutane-1-carboxylic acid (ACBC).

Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.

Abstract: Aminocycloalkyl cinnamide compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of local analgesia and anesthesia.

Abstract: Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.